Oppenheimer Stays Bullish On Sarepta As Concerns Continue To Swirl
February 16, 2017 at 09:50 AM EST
Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) have declined sharply, with continued concerns around reimbursement and competition. ...